The gains (losses) resulting from change in the fair value of purchase consideration payable.

No definition available.

Name:	ayr_GainLossOnChangeInFairValueOfPurchaseConsideration
Namespace Prefix:	ayr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from earn out consideration.

+ References

No definition available.

+ Details

Name:	ayr_IncreaseDecreaseThroughEarnOutConsideration
Namespace Prefix:	ayr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from earn out consideration, in shares.

+ References

No definition available.

+ Details

Name:	ayr_IncreaseDecreaseThroughEarnOutConsiderationShares
Namespace Prefix:	ayr_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of payment for settlement of contingent consideration, financing activities.

+ References

No definition available.

+ Details

Name:	ayr_PaymentForSettlementOfContingentConsiderationFinancingActivities
Namespace Prefix:	ayr_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2022-03-24
-Paragraph B64
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2022-03-24
-Paragraph B67
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period. Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B12
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_CurrentLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B12
-Subparagraph b
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_NoncurrentLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_NotionalAmount
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_ContingentConsiderationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_SiraAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_SiraAndCultivaunaAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_OasisAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_GsdAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_PaNaturalAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_CultivaunaLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=ayr_HerbalRemediesBusinessCombinationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

DERIVATIVE LIABILITIES Warrants - Purchase Consideration and Contingent Consideration (Details) - USD ($) shares in Thousands, $ in Thousands	1 Months Ended		12 Months Ended
	May 31, 2022	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Oct. 04, 2021	Mar. 23, 2021
DERIVATIVE LIABILITIES
Payment for settlement of contingent consideration		$ 10,000	$ 10,000
Reduction in long term debt		14,934
Share issuance - earn-out consideration		11,748	11,748
Fair value gain on financial liabilities			63,088	$ 83,759
Current liabilities			228,994	152,336
Contingent consideration
DERIVATIVE LIABILITIES
Fair value gain on financial liabilities		$ 3,186
Sira Acquisition
DERIVATIVE LIABILITIES
Contingent consideration fair value			26,652	25,316
Sira and Cultivauna \| Contingent consideration
DERIVATIVE LIABILITIES
Non current liabilities			26,661
Oasis
DERIVATIVE LIABILITIES
Contingent consideration			0	28,667		$ 117,615
GSD
DERIVATIVE LIABILITIES
Contingent consideration			63,429	91,671
GSD \| Contingent consideration
DERIVATIVE LIABILITIES
Current liabilities			$ 63,429
PA Natural Acquisition
DERIVATIVE LIABILITIES
Contingent consideration				$ 39,868	$ 39,041
Share issuance - earn-out consideration (Shares)			1,029
Cultivauna, LLC
DERIVATIVE LIABILITIES
Contingent consideration			$ 9
Herbal remedies
DERIVATIVE LIABILITIES
Fair value adjustment on the purchase consideration settlement	$ 1,780